Clinical-pathological study of AIDS descriptive criteria and evaluate the role of HIV awareness among infected patients visiting public health centers in Thi Qar Governorate between November 2023 and February 2024
Keywords:
AIDS, Thi-Qar, incidence, heterosexual, transmission, HIVAbstract
Acquired immunodeficiency syndrome (AIDS) represents the advanced stage of HIV infection. HIV targets and infects the body's white blood cells, and its incidence has been on the rise in Thi-Qar city, Iraq. This study aims to assess the incidence of HIV infection in this region from 1986 to 2024.This retrospective cross-sectional study was conducted from November 30, 2023, to February 24, 2024. A total of 144 patients diagnosed with AIDS in Thi-Qar province, Iraq, were included. Data were obtained from the Thi-Qar Medical Institute and the Health Directorate's database, following legal and ethical approval. The data collection process involved a thorough review of each patient's medical history and physical examination. HIV diagnosis was confirmed using PCR techniques, and statistical analysis was performed using SPSS software.The Results were among the 144 patients, 117 were male (81%) and 27 were female (19%). The study identified various transmission routes: 7% of patients had a history of blood transfusion, 26% were infected through heterosexual contact, 5% through homosexual contact, 2% through both heterosexual and homosexual contacts, 1% through vertical transmission, 13% through husband-to-wife transmission, and 46% through unknown causes. The incidence of HIV infection gradually increased, from a single case in 1986 to 21 cases in 2019. The number of cases then rose more sharply, reaching a peak of 144 patients by early 2024. The study highlights the increasing incidence of HIV infection in Thi-Qar province, particularly from 2019 to 2024. The most common transmission routes were unknown causes, heterosexual contact, husband-to-wife transmission, blood transfusion, homosexual contact, and vertical transmission. The highest incidence was observed among young adults aged 20-50 years
Downloads
Metrics
References
Kumah, E., Boakye, D. S., Boateng, R., & Agyei, E. (2023). Advancing the global fight against HIV/Aids: Strategies, barriers, and the road to eradication. Annals of global health, 89(1), 83.
van Schalkwyk, C., Mahy, M., Johnson, L. F., & Imai-Eaton, J. W. (2024). Updated data and methods for the 2023 UNAIDS HIV estimates. JAIDS Journal of Acquired Immune Deficiency Syndromes, 95(1S), e1-e4.
Blut, A. (2016). German Advisory Committee Blood (Arbeitskreis Blut), Subgroup ‘Assessment of Pathogens Transmissible by Blood’Human Immunodeficiency Virus (HIV). Transfusion Medicine and Hemotherapy, 43(3), 203-209.
Nyamweya, S., Hegedus, A., Jaye, A., Rowland‐Jones, S., Flanagan, K. L., & Macallan, D. C. (2013). Comparing HIV‐1 and HIV‐2 infection: Lessons for viral immunopathogenesis. Reviews in medical virology, 23(4), 221-240.
Beres, L. K., Simbeza, S., Holmes, C. B., Mwamba, C., Mukamba, N., Sharma, A., ... & Sikazwe, I. (2019). Human-centered design lessons for implementation science: improving the implementation of a patient-centered care intervention. JAIDS Journal of Acquired Immune Deficiency Syndromes, 82, S230-S243.
Anderson, R. M., & Medley, G. F. (1988). Epidemiology of HIV infection and AIDS: incubation and infectious periods, survival and vertical transmission. Aids, 2, S57-64.
Jani, C., Patel, K., Walker, A., Singh, H., Al Omari, O., Crowley, C., ... & Shalhoub, J. (2021). Trends of HIV mortality between 2001 and 2018: an observational analysis. Tropical Medicine and Infectious Disease, 6(4), 173.
Sani, M. U., Mohammed, A. Z., Adamu, B., Yusuf, S. M., Samaila, A. A., & Borodo, M. M. (2006). AIDS mortality in a tertiary health institution: A four-year review. Journal of the National Medical Association, 98(6), 862.
Syndrome, A. I. (2024). Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association. Consensus on diagnosis and management of immunological non-responder in acquired immunodeficiency syndrome (version 2023). Chin J Infect, 42, 3-13.
Mominur Rahman, M., Islam, F., Saidur Rahaman, M., Sultana, N. A., Fahim, N. F., & Ahmed, M. (2021). Studies on the prevalence of HIV/AIDS in Bangladesh including other developing countries. Advances in Traditional Medicine, 1-12.
Bhatti, A. B., Usman, M., & Kandi, V. (2016). Current scenario of HIV/AIDS, treatment options, and major challenges with compliance to antiretroviral therapy. Cureus, 8(3).
White, D. L., Oluyomi, A., Royse, K., Dong, Y., Nguyen, H., Chang, E., ... & Chiao, E. (2019). Incidence of AIDS-related Kaposi sarcoma in all 50 United States from 2000 to 2014. JAIDS Journal of Acquired Immune Deficiency Syndromes, 81(4), 387-394.
Asala, A. F., Bhuiyan, A. R., Mitra, A. K., Mendy, V. L., Mawson, A. R., & Akil, L. (2019). Trends in HIV/AIDS incidence rate in Mississippi, 2008-2019. Age, 10, 100-000.
Spicer, C. M., & Ford, M. A. (Eds.). (2012). Monitoring HIV care in the United States: indicators and data systems.
Ghys, P. D., Williams, B. G., Over, M., Hallett, T. B., & Godfrey-Faussett, P. (2018). Epidemiological metrics and benchmarks for a transition in the HIV epidemic. PLoS medicine, 15(10), e1002678..
Bossonario, P. A., Ferreira, M. R. L., Andrade, R. L. D. P., Sousa, K. D. L. D., Bonfim, R. O., Saita, N. M., & Monroe, A. A. (2022). Risk factors for HIV infection among adolescents and the youth: a systematic review. Revista latino-americana de enfermagem, 30, e3697.
Butdabut, A., & Homchampa, P. (2021). Factors predicting sexual risk behaviors of adolescents in north-eastern Thailand. In pHealth 2021 (pp. 273-276). IOS Press
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
